eMedicine Specialties > Emergency Medicine > Infectious Diseases

Malaria: Multimedia

Author: Miguel C Fernández, MD, FAAEM, FACEP, FACMT, Associate Clinical Professor; Medical and Managing Director, South Texas Poison Center, Department of Surgery/Emergency Medicine and Toxicology, University of Texas Health Science Center at San Antonio
Contributor Information and Disclosures

Updated: May 29, 2009

Multimedia

Malarial merozoites in the peripheral blood. Note...Media file 1: Malarial merozoites in the peripheral blood. Note that several of the merozoites have penetrated the erythrocyte membrane and entered the cell.
Malarial merozoites in the peripheral blood. Note...

Malarial merozoites in the peripheral blood. Note that several of the merozoites have penetrated the erythrocyte membrane and entered the cell.

This micrograph illustrates the trophozoite form,...Media file 2: This micrograph illustrates the trophozoite form, or immature-ring form, of the malarial parasite within peripheral erythrocytes. RBCs infected with trophozoites do not produce sequestrins and, therefore, are able to pass through the spleen.
This micrograph illustrates the trophozoite form,...

This micrograph illustrates the trophozoite form, or immature-ring form, of the malarial parasite within peripheral erythrocytes. RBCs infected with trophozoites do not produce sequestrins and, therefore, are able to pass through the spleen.

An erythrocyte filled with merozoites, which soon...Media file 3: An erythrocyte filled with merozoites, which soon will rupture the cell and attempt to infect other RBCs. Notice the darkened central portion of the cell; this is hemozoin, or malaria pigment, which is a paracrystalline precipitate formed when heme polymerase reacts with the potentially toxic heme stored within the erythrocyte. When treated with chloroquine, the enzyme heme polymerase is inhibited, leading to the heme-induced demise of non–chloroquine-resistant merozoites.
An erythrocyte filled with merozoites, which soon...

An erythrocyte filled with merozoites, which soon will rupture the cell and attempt to infect other RBCs. Notice the darkened central portion of the cell; this is hemozoin, or malaria pigment, which is a paracrystalline precipitate formed when heme polymerase reacts with the potentially toxic heme stored within the erythrocyte. When treated with chloroquine, the enzyme heme polymerase is inhibited, leading to the heme-induced demise of non–chloroquine-resistant merozoites.

A mature schizont within an erythrocyte. These RB...Media file 4: A mature schizont within an erythrocyte. These RBCs are sequestered in the spleen when malaria proteins, called sequestrins, on the RBC surface bind to endothelial cells within that organ. Sequestrins are only on the surfaces of erythrocytes that contain the schizont form of the parasite.
A mature schizont within an erythrocyte. These RB...

A mature schizont within an erythrocyte. These RBCs are sequestered in the spleen when malaria proteins, called sequestrins, on the RBC surface bind to endothelial cells within that organ. Sequestrins are only on the surfaces of erythrocytes that contain the schizont form of the parasite.

Schema of the life cycle of malaria. Image courte...Media file 5: Schema of the life cycle of malaria. Image courtesy of the Centers for Disease Control and Prevention.
Schema of the life cycle of malaria. Image courte...

Schema of the life cycle of malaria. Image courtesy of the Centers for Disease Control and Prevention.

More on Malaria

Overview: Malaria
Differential Diagnoses & Workup: Malaria
Treatment & Medication: Malaria
Follow-up: Malaria
Multimedia: Malaria
References

References

  1. Centers for Disease Control and Prevention. Malaria. Topic Home. Last updated May 21, 2009. Available at http://www.cdc.gov/malaria/index.htm.

  2. Cox-Singh J, Davis TM, Lee KS, et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis. Jan 15 2008;46(2):165-71. [Medline].

  3. [Guideline] Bailey JW, Williams J, Bain BJ, Parker-Williams J, Chiodini P. General Haematology Task Force. Guideline for laboratory diagnosis of malaria. London (UK): British Committee for Standards in Haematology. 2007;19. [Full Text].

  4. Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg. Dec 2007;77(6 Suppl):119-27. [Medline].

  5. de Oliveira AM, Skarbinski J, Ouma PO, et al. Performance of malaria rapid diagnostic tests as part of routine malaria case management in Kenya. Am J Trop Med Hyg. Mar 2009;80(3):470-4. [Medline].

  6. Hanson J, Hossain A, Charunwatthana P, et al. Hyponatremia in severe malaria: evidence for an appropriate anti-diuretic hormone response to hypovolemia. Am J Trop Med Hyg. Jan 2009;80(1):141-5. [Medline].

  7. [Guideline] World Health Organization. Guidelines for the Treatment of Malaria. 2006;[Full Text].

  8. [Guideline] Filler SJ, MacArthur JR, Parise M, Wirtz R, Eliades MJ, Dasilva A, et al. Locally acquired mosquito-transmitted malaria: a guide for investigations in the United States. MMWR Recomm Rep. Sep 8 2006;55:1-9. [Medline][Full Text].

  9. [Guideline] Centers for Disease Control and Prevention. Treatment of Malaria (Guidelines for Clinicians). Last updated May 18, 2009. [Full Text].

  10. Carmona-Fonseca J, Alvarez G, Maestre A. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment. Am J Trop Med Hyg. Feb 2009;80(2):188-93. [Medline].

  11. US Food and Drug Administration. FDA News. FDA Approves Coartem Tablets to Treat Malaria. April 8, 2009. Available at http://www.fda.gov/bbs/topics/NEWS/2009/NEW01989.html.

  12. Centers for Disease Control and Prevention. Atlanta, GA: DHHS; 2009. Malaria and Travelers. Available at http://www.cdc.gov/malaria/travel/index.htm.

  13. Ballou WR, Arevalo-Herrera M, Carucci D, et al. Update on the clinical development of candidate malaria vaccines. Am J Trop Med Hyg. Aug 2004;71(2 Suppl):239-47. [Medline].

  14. Barat LM, Bloland PB. Drug resistance among malaria and other parasites. Infect Dis Clin North Am. Dec 1997;11(4):969-87. [Medline].

  15. Bledsoe GH. Malaria primer for clinicians in the United States. South Med J. Dec 2005;98(12):1197-204; quiz 1205, 1230. [Medline].

  16. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA. Feb 26 2003;289(8):959-62. [Medline].

  17. Carter R, Mendis KN. Evolutionary and historical aspects of the burden of malaria. Clin Microbiol Rev. Oct 2002;15(4):564-94. [Medline].

  18. Centers for Disease Control and Prevention. The Impact of Malaria, a Leading Cause of Death Worldwide. Available at http://www.cdc.gov/malaria/impact/index.htm.

  19. Day N, Dondorp AM. The management of patients with severe malaria. Am J Trop Med Hyg. Dec 2007;77(6 Suppl):29-35. [Medline].

  20. Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States: a systematic review. JAMA. May 23 2007;297(20):2264-77. [Medline].

  21. Humar A, Ohrt C, Harrington MA, Pillai D, Kain KC. Parasight F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travelers. Am J Trop Med Hyg. Jan 1997;56(1):44-8. [Medline].

  22. Jong EC, McMullen R. Travel medicine problems encountered in emergency departments. Emerg Med Clin North Am. Feb 1997;15(1):261-81. [Medline].

  23. Malaria in an immigrant and travelers -- Georgia, Vermont, and Tennessee, 1996. MMWR Morb Mortal Wkly Rep. Jun 13 1997;46(23):536-9. [Medline].

  24. Maude RJ, Plewes K, Faiz MA, et al. Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?. Am J Trop Med Hyg. Jan 2009;80(1):126-32. [Medline].

  25. Murphy GS, Oldfield EC 3rd. Falciparum malaria. Infect Dis Clin North Am. Dec 1996;10(4):747-75. [Medline].

  26. Silver HM. Malarial infection during pregnancy. Infect Dis Clin North Am. Mar 1997;11(1):99-107. [Medline].

  27. World Health Organization. Global Malaria Programme (GMP). Available at http://www.who.int/malaria..

  28. World Health Organization. Malaria Rapid Diagnostic Tests. Available at http://www.wpro.who.int/sites/rdt/home.htm.

Further Reading

Keywords

malaria, paludism, paludismo, black water fever, blackwater fever, mosquito vector, plasmodia, species, mosquito, mosquito bite

Contributor Information and Disclosures

Author

Miguel C Fernández, MD, FAAEM, FACEP, FACMT, Associate Clinical Professor; Medical and Managing Director, South Texas Poison Center, Department of Surgery/Emergency Medicine and Toxicology, University of Texas Health Science Center at San Antonio
Miguel C Fernández, MD, FAAEM, FACEP, FACMT is a member of the following medical societies: American Academy of Clinical Toxicology, American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Medical Toxicology, American College of Occupational and Environmental Medicine, Society for Academic Emergency Medicine, and Texas Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Eric M Kardon, MD, FACEP, Attending Emergency Physician, Georgia Emergency Medicine Specialists; Physician, Division of Emergency Medicine, Athens Regional Medical Center
Eric M Kardon, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Eric L Weiss, MD, DTM&H, Director of Stanford Travel Medicine, Medical Director of Stanford Lifeflight, Assistant Professor, Departments of Emergency Medicine and Infectious Diseases, Stanford University School of Medicine
Eric L Weiss, MD, DTM&H is a member of the following medical societies: American College of Emergency Physicians, American College of Occupational and Environmental Medicine, American Medical Association, American Society of Tropical Medicine and Hygiene, Physicians for Social Responsibility, Southeastern Surgical Congress, Southern Association for Oncology, Southern Clinical Neurological Society, and Wilderness Medical Society
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD, Medical Director, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital
Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: WebMD Salary Employment

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.